{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:01:46Z","timestamp":1781640106616,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heart failure (HF) is a severe potential complication of myocardial infarction(MI). However precise mechanisms underlying progression from MI to HF are not yet fully understood. Exploring how plasma proteomic profiles of post-MI patients relate to cardiac function during follow-up can give insights into pathophysiological processes that contribute to HF development. We measured 4587 circulating proteins in 246 patients hospitalized for a first anterior Q-wave MI at 1, 3 and 12 months post-MI. Echocardiographic measurements of left-ventricular (LV) end-diastolic volume (EDV), LV ejection fraction (EF), and left atrial volume (AV), were assessed at hospital discharge, 3, and 12 months. Associations between protein and echocardiographic variables were assessed using pair-wise multivariate linear mixed-effects models. Median (IQR) age was 56 (46, 69) years, and 19% were women. Twenty-eight proteins were associated with LVEDV (linked to cardiac remodeling, vascular dysfunction, oxidative stress), twelve with AV (coronary artery disease, atherosclerosis, immune system), and eight with LVEF (cardiac hypertrophy, fibrosis, inflammation). Trajectories of all three echocardiographic variables were associated with NT-proBNP and BNP. Our results give an overview of the most important mechanisms related to the deterioration of cardiac function after MI, with cardiac stress, cardiac remodeling, vascular dysfunction, and inflammation emerging as central mechanisms.<\/jats:p>","DOI":"10.1038\/s41598-026-43659-6","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:44:37Z","timestamp":1773319477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma proteins and mechanisms involved in the evolvement of cardiac function after myocardial infarction"],"prefix":"10.1038","volume":"16","author":[{"given":"Teun B.","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Rizopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Pinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Kardys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Bauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"1","key":"43659_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12872-023-03231-w","volume":"23","author":"N Salari","year":"2023","unstructured":"Salari, N. et al. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovasc. Disord. 23 (1), 206 (2023).","journal-title":"BMC Cardiovasc. Disord."},{"key":"43659_CR2","doi-asserted-by":"crossref","unstructured":"Carberry, J., Marquis-Gravel, G., O\u2019Meara, E. & Docherty, K. F. Where Are We With Treatment and Prevention of Heart Failure in Patients Post\u2013Myocardial Infarction? JACC (Heart Failure, 2024).","DOI":"10.1016\/j.jchf.2024.04.025"},{"issue":"11","key":"43659_CR3","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1161\/CIRCRESAHA.118.313568","volume":"124","author":"IY Elgendy","year":"2019","unstructured":"Elgendy, I. Y., Mahtta, D. & Pepine, C. J. Medical therapy for heart failure caused by ischemic heart disease. Circul. Res. 124 (11), 1520\u20131535 (2019).","journal-title":"Circul. Res."},{"issue":"5","key":"43659_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4330\/wjc.v9.i5.407","volume":"9","author":"T Cahill","year":"2017","unstructured":"Cahill, T. & Kharbanda, R. Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk. World J. Cardiol. 9 (5), 407\u2013415 (2017).","journal-title":"World J. Cardiol."},{"issue":"6716","key":"43659_CR5","doi-asserted-by":"publisher","first-page":"eads5749","DOI":"10.1126\/science.ads5749","volume":"385","author":"EJ Topol","year":"2024","unstructured":"Topol, E. J. The revolution in high-throughput proteomics and AI. Science 385 (6716), eads5749 (2024).","journal-title":"Science"},{"key":"43659_CR6","doi-asserted-by":"publisher","first-page":"104655","DOI":"10.1016\/j.ebiom.2023.104655","volume":"93","author":"TB Petersen","year":"2023","unstructured":"Petersen, T. B. et al. HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms. Ebiomedicine 93, 104655 (2023).","journal-title":"Ebiomedicine"},{"issue":"10","key":"43659_CR7","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.amjcard.2010.06.071","volume":"106","author":"M Fertin","year":"2010","unstructured":"Fertin, M. et al. Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). Am. J. Cardiol. 106 (10), 1410\u20131416 (2010).","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"43659_CR8","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.amjcard.2006.06.011","volume":"98","author":"C Savoye","year":"2006","unstructured":"Savoye, C. et al. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). Am. J. Cardiol. 98 (9), 1144\u20131149 (2006).","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"43659_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.acvd.2011.11.001","volume":"105","author":"N Lamblin","year":"2012","unstructured":"Lamblin, N., Fertin, M., de Groote, P. & Bauters, C. Incidence, determinants and consequences of left atrial remodelling after a first anterior myocardial infarction. Arch. Cardiovasc. Dis. 105 (1), 18\u201323 (2012).","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"12","key":"43659_CR10","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One. 5 (12), e15004 (2010).","journal-title":"PLoS One"},{"issue":"1","key":"43659_CR11","doi-asserted-by":"publisher","first-page":"19202","DOI":"10.1038\/s41598-019-55727-1","volume":"9","author":"M Cuvelliez","year":"2019","unstructured":"Cuvelliez, M. et al. Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction. Sci. Rep. 9 (1), 19202 (2019).","journal-title":"Sci. Rep."},{"issue":"6220","key":"43659_CR12","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Tissue-based map of the human proteome. Science 347 (6220), 1260419 (2015).","journal-title":"Science"},{"issue":"1","key":"43659_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. Nat. Genet. 25 (1), 25\u201329 (2000).","journal-title":"Nat. Genet."},{"issue":"suppl_2","key":"43659_CR14","doi-asserted-by":"publisher","first-page":"W305","DOI":"10.1093\/nar\/gkp427","volume":"37","author":"J Chen","year":"2009","unstructured":"Chen, J., Bardes, E. E., Aronow, B. J. & Jegga, A. G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37 (suppl_2), W305\u2013W11 (2009).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"43659_CR15","doi-asserted-by":"publisher","first-page":"101297","DOI":"10.1016\/j.jbc.2021.101297","volume":"297","author":"SK Barrick","year":"2021","unstructured":"Barrick, S. K. & Greenberg, M. J. Cardiac myosin contraction and mechanotransduction in health and disease. J. Biol. Chem. 297 (5), 101297 (2021).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"43659_CR16","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/cells8121483","volume":"8","author":"C Rodr\u00edguez","year":"2019","unstructured":"Rodr\u00edguez, C. & Mart\u00ednez-Gonz\u00e1lez, J. The role of lysyl oxidase enzymes in cardiac function and remodeling. Cells 8 (12), 1483 (2019).","journal-title":"Cells"},{"issue":"1","key":"43659_CR17","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1038\/ncomms13710","volume":"7","author":"J Yang","year":"2016","unstructured":"Yang, J. et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat. Commun. 7 (1), 13710 (2016).","journal-title":"Nat. Commun."},{"issue":"33","key":"43659_CR18","doi-asserted-by":"publisher","first-page":"27480","DOI":"10.1074\/jbc.M112.358929","volume":"287","author":"J Ma","year":"2012","unstructured":"Ma, J. et al. Deficiency of Capn4 gene inhibits nuclear factor-\u03baB (NF-\u03baB) protein signaling\/inflammation and reduces remodeling after myocardial infarction. J. Biol. Chem. 287 (33), 27480\u201327489 (2012).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"43659_CR19","doi-asserted-by":"publisher","first-page":"6625","DOI":"10.3390\/ijms25126625","volume":"25","author":"M Ortega","year":"2024","unstructured":"Ortega, M. et al. Novel fibrillar and non-fibrillar collagens involved in fibrotic scar formation after myocardial infarction. Int. J. Mol. Sci. 25 (12), 6625 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl_1","key":"43659_CR20","doi-asserted-by":"publisher","first-page":"AP2059","DOI":"10.1161\/res.131.suppl_1.P2059","volume":"131","author":"YW Lu","year":"2022","unstructured":"Lu, Y. W. et al. Abstract P2059: Poly (rC)-binding Protein-1 (Pcbp1) Is essential for heart development. Circ. Res. 131 (Suppl_1), AP2059\u2013AP (2022).","journal-title":"Circ. Res."},{"key":"43659_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.omtn.2021.06.003","volume":"25","author":"Y Zou","year":"2021","unstructured":"Zou, Y. et al. The regulatory roles of aminoacyl-tRNA synthetase in cardiovascular disease. Mol. Ther Nucleic Acids. 25, 372\u2013387 (2021).","journal-title":"Mol. Ther Nucleic Acids"},{"issue":"1","key":"43659_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.healun.2023.09.003","volume":"43","author":"E-M Jutant","year":"2024","unstructured":"Jutant, E-M. et al. Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension. J. Heart Lung Transpl.. 43 (1), 120\u2013133 (2024).","journal-title":"J. Heart Lung Transpl."},{"key":"43659_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-018-0905-2","volume":"18","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. A genetic variant near adaptor-related protein complex 2 alpha 2 subunit gene is associated with coronary artery disease in a Chinese population. BMC Cardiovasc. Disord. 18, 1\u20138 (2018).","journal-title":"BMC Cardiovasc. Disord."},{"issue":"6","key":"43659_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1161\/01.ATV.0000166548.65753.1e","volume":"25","author":"LL Rudel","year":"2005","unstructured":"Rudel, L. L., Lee, R. G. & Parini, P. ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia. Arterioscler. Thromb. Vasc Biol. 25 (6), 1112\u20131118 (2005).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"3","key":"43659_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00018-022-04177-6","volume":"79","author":"F Yang","year":"2022","unstructured":"Yang, F. et al. MicroRNA-22 promoted osteogenic differentiation of valvular interstitial cells by inhibiting CAB39 expression during aortic valve calcification. Cell. Mol. Life Sci. 79 (3), 146 (2022).","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"43659_CR26","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1161\/ATVBAHA.117.310020","volume":"37","author":"L Zhang","year":"2017","unstructured":"Zhang, L. et al. Novel pathological role of hnRNPA1 (heterogeneous nuclear ribonucleoprotein A1) in vascular smooth muscle cell function and neointima hyperplasia. Arterioscler. Thromb. Vasc Biol. 37 (11), 2182\u20132194 (2017).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"1","key":"43659_CR27","doi-asserted-by":"publisher","first-page":"e001266","DOI":"10.1161\/JAHA.114.001266","volume":"4","author":"B Gravez","year":"2015","unstructured":"Gravez, B. et al. Aldosterone promotes cardiac endothelial cell proliferation in vivo. J. Am. Heart Assoc. 4 (1), e001266 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"43659_CR28","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.redox.2022.102468","volume":"56","author":"L Mei","year":"2022","unstructured":"Mei, L. et al. Fibroblast growth factor 7 alleviates myocardial infarction by improving oxidative stress via PI3K\u03b1\/AKT-mediated regulation of Nrf2 and HXK2. Redox Biol. 56, 102468 (2022).","journal-title":"Redox Biol."},{"key":"43659_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12011-018-1464-1","volume":"188","author":"B Turan","year":"2019","unstructured":"Turan, B. A brief overview from the physiological and detrimental roles of zinc homeostasis via zinc transporters in the heart. Biol. Trace Elem. Res. 188, 160\u2013176 (2019).","journal-title":"Biol. Trace Elem. Res."},{"issue":"1","key":"43659_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4161\/auto.5.1.7303","volume":"5","author":"N Gurusamy","year":"2009","unstructured":"Gurusamy, N., Lekli, I., Gherghiceanu, M., Popescu, L. M. & Das, D. K. BAG-1 induces autophagy for cardiac cell survival. Autophagy 5 (1), 120\u2013121 (2009).","journal-title":"Autophagy"},{"issue":"7","key":"43659_CR31","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ajpath.2022.03.014","volume":"192","author":"T Leigh","year":"2022","unstructured":"Leigh, T. et al. Deletion of LDLRAP1 induces atherosclerotic plaque formation, insulin resistance, and dysregulated insulin response in adipose tissue. Am. J. Pathol. 192 (7), 1092\u20131108 (2022).","journal-title":"Am. J. Pathol."},{"issue":"1","key":"43659_CR32","doi-asserted-by":"publisher","first-page":"34929","DOI":"10.1038\/srep34929","volume":"6","author":"C-Q Sun","year":"2016","unstructured":"Sun, C-Q. et al. Elevated type II secretory phospholipase A2 increases the risk of early atherosclerosis in patients with newly diagnosed metabolic syndrome. Sci. Rep. 6 (1), 34929 (2016).","journal-title":"Sci. Rep."},{"issue":"2","key":"43659_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/MCA.0000000000000322","volume":"27","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. Altered expression of lysosomal hydrolase, acid \u03b1-glucosidase, gene in coronary artery disease. Coron. Artery Dis. 27 (2), 104\u2013108 (2016).","journal-title":"Coron. Artery Dis."},{"issue":"1","key":"43659_CR34","doi-asserted-by":"publisher","first-page":"e10384","DOI":"10.1002\/btm2.10384","volume":"8","author":"Q Liu","year":"2023","unstructured":"Liu, Q. et al. Identification of PIK3CG as a hub in septic myocardial injury using network pharmacology and weighted gene co-expression network analysis. Bioeng. Transl. Med. 8 (1), e10384 (2023).","journal-title":"Bioeng. Transl. Med."},{"key":"43659_CR35","doi-asserted-by":"publisher","first-page":"101335","DOI":"10.1016\/j.ijcha.2024.101335","volume":"51","author":"D Tu","year":"2024","unstructured":"Tu, D., Xu, Q., Zuo, X. & Ma, C. Uncovering hub genes and immunological characteristics for heart failure utilizing RRA, WGCNA and Machine learning. IJC Heart Vascul. 51, 101335 (2024).","journal-title":"IJC Heart Vasculat."},{"issue":"7","key":"43659_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41419-023-05948-0","volume":"14","author":"Y Sun","year":"2023","unstructured":"Sun, Y., Xu, C., Jiang, Z. & Jiang, X. DEF6 (differentially exprehomolog) exacerbates pathological cardiac hypertrophy via RAC1. Cell. Death Dis. 14 (7), 483 (2023).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"43659_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2478\/fzm-2024-0005","volume":"4","author":"T Jin","year":"2024","unstructured":"Jin, T. et al. Notum protects against myocardial infarction-induced heart dysfunction by alleviating cardiac fibrosis. Frigid Zone Med. 4 (1), 41\u201350 (2024).","journal-title":"Frigid Zone Med."},{"issue":"11","key":"43659_CR38","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1161\/ATVBAHA.112.300310","volume":"32","author":"W Chen","year":"2012","unstructured":"Chen, W. et al. Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. Arterioscler. Thromb. Vasc Biol. 32 (11), 2598\u20132608 (2012).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"11","key":"43659_CR39","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1172\/JCI99659","volume":"128","author":"S-J Lee","year":"2018","unstructured":"Lee, S-J. et al. Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction. J. Clin. Investig. 128 (11), 5018\u20135033 (2018).","journal-title":"J. Clin. Investig."},{"issue":"2","key":"43659_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4330\/wjc.v7.i2.52","volume":"7","author":"MA Garza","year":"2015","unstructured":"Garza, M. A., Wason, E. A. & Zhang, J. Q. Cardiac remodeling and physical training post myocardial infarction. World J. Cardiol. 7 (2), 52 (2015).","journal-title":"World J. Cardiol."},{"issue":"36","key":"43659_CR41","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh, T. A. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 42 (36), 3599\u20133726 (2021).","journal-title":"Eur. Heart J."},{"issue":"6","key":"43659_CR42","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/ejhf.2805","volume":"25","author":"EK Gard","year":"2023","unstructured":"Gard, E. K. et al. Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction. Eur. J. Heart Fail. 25 (6), 806\u2013814 (2023).","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"43659_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","volume":"17","author":"L Adamo","year":"2020","unstructured":"Adamo, L., Rocha-Resende, C., Prabhu, S. D. & Mann, D. L. Reappraising the role of inflammation in heart failure. Nat. Rev. Cardiol. 17 (5), 269\u2013285 (2020).","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"43659_CR44","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1161\/CIRCRESAHA.124.323658","volume":"134","author":"I Hilgendorf","year":"2024","unstructured":"Hilgendorf, I., Frantz, S. & Frangogiannis, N. G. Repair of the infarcted heart: cellular effectors, molecular mechanisms and therapeutic opportunities. Circul. Res. 134 (12), 1718\u20131751 (2024).","journal-title":"Circul. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43659-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43659-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43659-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:51:08Z","timestamp":1781639468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43659-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43659"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43659-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13251"}}